Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
90.42
+0.18 (0.20%)
At close: May 6, 2026, 4:00 PM EDT
92.00
+1.58 (1.75%)
Pre-market: May 7, 2026, 8:04 AM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $4.94 billion as of May 7, 2026. Its market cap has increased by 603.52% in one year.
Market Cap
4.94B
Enterprise Value
3.72B
1-Year Change
603.52%
Ranking
Category
Stock Price
$90.42
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $4.94B, an increase of 2,932.57%. That is a compound annual growth rate of 262.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 4.94B | 179.75% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 5.66B |
| Scholar Rock Holding | 5.62B |
| Corcept Therapeutics | 5.60B |
| PTC Therapeutics | 5.52B |
| Caris Life Sciences | 5.41B |
| Legend Biotech | 5.36B |
| CRISPR Therapeutics AG | 5.31B |
| Apellis Pharmaceuticals | 5.26B |